DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.compose your message
message sent
email sent successfully
Trusted Resources: News & Events
Latest announcements and gatherings
Chief Patient Officer Summit
July 18-20 | Boston, Massachusetts
This conference focuses on building end-to-end support for patients with rare diseases. SCDAA President and CEO Regina Hartfield will participate on a panel about increasing diversity, equity and inclusion in clinical trials. Patients, caregivers and patient advocates are welcome. Register by May 26 to receive a discount.
+myBinderRelated Content
-
news & eventsSickle Cell Disease Association of Illinois Management of Sickle Cell Disease ConferenceThe Sickle Cell Disease Association of I...
-
news & eventsCurrent Advocacy Work in Sickle Cell Disease: The Global PerspectiveJoin the Global Alliance of Sickle Cell ...
-
news & eventsMARAC Statement: Crizanlizumab (Adakveo)July 7, 2023 - SCDAA’s Medical and Res...
-
education & researchFolate supplementation in people with sickle cell diseaseBACKGROUND: Sickle cell disease is a gr...
-
news & eventsCRISPR could end sickle cell disease, but signing up black patients for clinical trials will be a hard sellThe first attempts to use a groundbreaki...
-
education & researchRandomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased ...Treatment of vaso-occlusive crises (VOC)...
-
news & eventsGene Therapy for Blood DisordersIn the context of intense scrutiny over ...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.